Caris & Company Downgrades Endo Pharmaceuticals (ENDP) to Above Average
Tweet Send to a Friend
Caris & Company downgrades Endo Pharmaceuticals Holdings Inc. (Nasdaq ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


